These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25555707)

  • 21. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
    Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
    Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through modulating mitochondrial dynamics.
    Lee SB; Youn J; Jang W; Yang HO
    Neurochem Int; 2019 Oct; 129():104491. PubMed ID: 31229553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental modeling of functional deficiency of the nigrostriatal dopaminergic system in mice].
    Kozina EA; Khaindrava VG; Kudrin VS; Kucherianu VG; Klodt PD; Bocharov EV; Raevskiĭ KS; Kryzhanovskiĭ GN; Ugriumov MV
    Ross Fiziol Zh Im I M Sechenova; 2010 Mar; 96(3):270-82. PubMed ID: 20535997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
    Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
    J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
    J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Mattson MP
    J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.
    Mu X; He GR; Yuan X; Li XX; Du GH
    Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.
    Benskey MJ; Manfredsson FP; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2015 Jan; 46():1-11. PubMed ID: 25447324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ
    Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain.
    Ren YR; Nishida Y; Yoshimi K; Yasuda T; Jishage K; Uchihara T; Yokota T; Mizuno Y; Mochizuki H
    J Neurochem; 2006 Sep; 98(6):1810-6. PubMed ID: 16787402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease.
    Huang D; Wang Z; Tong J; Wang M; Wang J; Xu J; Bai X; Li H; Huang Y; Wu Y; Ma Y; Yu M; Huang F
    Neuroscience; 2018 Jan; 369():303-313. PubMed ID: 29196026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.
    Korecka JA; Eggers R; Swaab DF; Bossers K; Verhaagen J
    Restor Neurol Neurosci; 2013; 31(2):155-67. PubMed ID: 23271419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease.
    Kurosaki R; Muramatsu Y; Kato H; Araki T
    Pharmacol Biochem Behav; 2004 May; 78(1):143-53. PubMed ID: 15159144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
    De Luca MA; Cauli O; Morelli M; Simola N
    J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
    Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
    Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.